[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100514309":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":39,"responsibleParty":58,"collaborators":61,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":12,"enrollmentInfo":79,"targetDuration":12,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":42,"whyStopped":12,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"University Institute of Maia","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control Group","NO_INTERVENTION","The control group will receive neoadjuvant chemotherapy alone (standard of care).",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Experimental Group","EXPERIMENTAL","The experimental group will receive neoadjuvant chemotherapy (standard of care) in conjunction with an exercise intervention. The exercise intervention will be implemented concurrently for the full duration of the neoadjuvant chemotherapy treatment.",[18],"Behavioral: Combined Aerobic and Resistance Exercise",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","Combined Aerobic and Resistance Exercise","Apart from the neoadjuvant chemotherapy treatment (standard of care), participants allocated to the experimental group will additionally participate in a supervised physical exercise program that comprises 3 weekly sessions during the months that the patient is undergoing chemotherapy treatment. Each 75-minute session will comprise a 10-minute warm up, 30 minutes of strength training involving exercise for the major muscle groups, 30 minutes of aerobic training at 40-89% of heart rate reserve and a 5-minute cool down.",[14],[26],{"name":27,"affiliation":28,"role":29},"Nuno Rato, MSc","University of Maia","PRINCIPAL_INVESTIGATOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":12,"email":35},"Nuno D Rato, MSc","CONTACT","+351 919985852","nuno.rato@umaia.pt",{"name":37,"role":33,"phone":12,"phoneExt":12,"email":38},"Alberto Alves, PhD","ajalves@umaia.pt",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Centro Hospitalar Vila Nova Gaia e Espinho","RECRUITING","Vila Nova de Gaia","Porto District","4434-502","Portugal","PT",{"type":49,"coordinates":50},"Point",[51,52],-8.61241,41.12401,{"lat":52,"lon":51},[55,57],{"name":27,"role":33,"phone":56,"phoneExt":12,"email":35},"+351919985852",{"name":27,"role":29,"phone":12,"phoneExt":12,"email":12},{"type":29,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Alberto Alves","Principal Investigator",[62,64,66,68],{"name":63,"class":6},"Aveiro University",{"name":65,"class":6},"Centro Hospitalar de Vila Nova de Gaia\u002FEspinho",{"name":67,"class":6},"Associacao de Investigacao de Cuidados de Suporte em Oncologia",{"name":28,"class":6},"100514309","improving-response-to-chemotherapy-by-adding-physical-exercise-in-the-neoadjuvant-setting-of-breast-cancer-patients-100514309",false,"NCT05976815","Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients","Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients - The KEYMOVE Randomized Controlled Trial","KEYMOVE","Inclusion Criteria:\n\n1. being female gender;\n2. age equals or greater than 18 years old;\n3. having a newly diagnosed histologically confirmed breast carcinoma IA-IIIC;\n4. planned to receive neoadjuvant chemotherapy with anthracyclines or taxanes, that might be associated to anti-HER2 drugs;\n5. being followed by the oncology department of the CHVNG\u002FE;\n6. medical oncologists consents the practice of physical exercise;\n7. the patient is capable of providing written informed consent;\n8. the participant accepts to be allocated to the control or experimental group, according to the randomization.\n\nExclusion Criteria:\n\n1. previous cancer diagnostic;\n2. evidence of synchronous oncologic disease;\n3. physical or psychiatric contraindication to the practice of physical exercise.","FEMALE","18 Years",{"count":80,"type":81},86,"ESTIMATED","INTERVENTIONAL",[84],"NA","One of the recommended treatments for breast cancer is neoadjuvant chemotherapy (NCT), however, only 20% of the patients subject to this therapy present pathologic complete response (pCR). If exercise-induced tumour size reductions observed in preclinical studies translates to humans, physical training could emerge as a way of increasing rates of pCR to NCT, which would be a valuable clinical achievement. The present randomized controlled trial primary aim is to assess the impact of a physical exercise intervention the NCT efficacy. Following a parallel-arm design, 86 women with primary BC will be allocated 1:1 to a NCT + exercise (experimental) or NCT alone (control) group. The primary outcome is the rate of pCR in each group. Secondary outcomes include treatment tolerability and compliance, tumour infiltrating lymphocytes, ki67, immune, inflammatory, matricellular and myogenic markers, physical fitness, accelerometry, quality of life and body composition.",[87],"Breast Cancer",[87,89,90,91,92],"Neoadjuvant Chemotherapy","Physical Exercise","Pathologic Complete Response","Immune System","2025-03-25",{"date":95,"type":96},"2025-03-26","ACTUAL",{"date":98,"type":96},"2023-07-31",{"date":100,"type":81},"2026-08-01",{"name":5,"class":6},1]